Cargando…

Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis

The purpose was to compare time-based vs anti-Xa-based anticoagulation strategies in patients on ECMO. We conducted a systematic review and meta-analysis using multiple electronic databases and included studies from inception to July 19, 2019. The proportion of bleeding, thrombosis, and mortality we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willems, Ariane, Roeleveld, Peter P, Labarinas, Sonia, Cyrus, John W, Muszynski, Jennifer A, Nellis, Marianne E, Karam, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216320/ https://www.ncbi.nlm.nih.gov/pubmed/32862767 http://dx.doi.org/10.1177/0267659120952982

Ejemplares similares

Epidemiology of the Use of Hemostatic Agents in Children Supported by Extracorporeal Membrane Oxygenation: A Pediatric Health Information System Database Study
por: Nellis, Marianne E., et al.
Publicado: (2021)

Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017)

Assessing Anticoagulation in Neonates With Congenital Diaphragmatic Hernia During Extracorporeal Membrane Oxygenation: Does Anti-Factor Xa or Thromboelastometry Provide Additional Benefit?
por: Perez Ortiz, Alba, et al.
Publicado: (2021)

Endogenous glycosaminoglycan anticoagulation in extracorporeal membrane oxygenation
por: MacLaren, Graeme, et al.
Publicado: (2014)

Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation
por: Ranucci, Marco, et al.
Publicado: (2011)

How to manage anticoagulation during extracorporeal membrane oxygenation
por: Levy, Jerrold H., et al.
Publicado: (2022)

Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children
por: Chegondi, Madhuradhar, et al.
Publicado: (2022)

Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation
por: Kornfehl, Andrea, et al.
Publicado: (2023)

Plasma in the PICU: why and when should we transfuse?
por: Labarinas, Sonia, et al.
Publicado: (2013)

Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study
por: Descamps, Richard, et al.
Publicado: (2021)

Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
por: Nguyen, Tung Phi, et al.
Publicado: (2021)

Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
por: Han, Sang Jin, et al.
Publicado: (2011)

Anticoagulation with direct thrombin inhibitors during extracorporeal membrane oxygenation
por: Burstein, Barry, et al.
Publicado: (2019)

Sodium alginate-hydrogel coatings on extracorporeal membrane oxygenation for anticoagulation
por: Gao, Wenqing, et al.
Publicado: (2022)

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review
por: Valdes, Carlos A., et al.
Publicado: (2023)

Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients
por: Cho, Hwa Jin, et al.
Publicado: (2017)

Anticoagulation in COVID-19-positive Patients on Venovenous Extracorporeal Membrane Oxygenation
por: Patel, Mayuri, et al.
Publicado: (2022)

Context-Responsive Anticoagulation Reduces Complications in Pediatric Extracorporeal Membrane Oxygenation
por: Lin, John C., et al.
Publicado: (2021)

Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review
por: Rajsic, Sasa, et al.
Publicado: (2022)

Anticoagulation Management during Extracorporeal Membrane Oxygenation—A Mini-Review
por: Burša, Filip, et al.
Publicado: (2022)

Controversies in extracorporeal membrane oxygenation: Immediate versus watchful waiting for venoarterial extracorporeal membrane oxygenation venting
por: Cavayas, Yiorgos Alexandros, et al.
Publicado: (2021)

Monitoring anticoagulation during extracorporeal membrane oxygenation in patients with acute respiratory failure
por: Panigada, M, et al.
Publicado: (2013)

COVID-19 necrotising pneumonia and extracorporeal membrane oxygenation: a challenge for anticoagulation
por: Goursaud, Suzanne, et al.
Publicado: (2020)

Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
por: Seelhammer, Troy G., et al.
Publicado: (2021)

Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
por: Guo, Zhen, et al.
Publicado: (2021)

The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation
por: Lee, Jae Ha, et al.
Publicado: (2022)

Accuracy of Transcutaneous Carbon Dioxide Measurement in Premature Infants
por: Janaillac, Marie, et al.
Publicado: (2016)

Identifying Prognostic Criteria for Survival after Resuscitation Assisted by Extracorporeal Membrane Oxygenation
por: Brunner, Alexandrine, et al.
Publicado: (2016)

Efficacy of Prostacyclin Anticoagulation in Critically Ill Patients Requiring Extracorporeal Support: A Systematic Review and Meta-Analysis
por: Aldairi, Nedaa, et al.
Publicado: (2023)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
por: Ma, Min, et al.
Publicado: (2022)

Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment
por: Han, Sung Joon, et al.
Publicado: (2018)

Extracorporeal membrane oxygenation without systemic anticoagulation: a case-series in challenging conditions
por: Fina, Dario, et al.
Publicado: (2020)

Commentary: To bleed or not to bleed, that is the question—Anticoagulation in surgical patients on prolonged extracorporeal membrane oxygenation
por: Schweiger, Thomas, et al.
Publicado: (2020)

The Changing Landscape of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation: Use of the Direct Thrombin Inhibitors
por: Neunert, Cindy, et al.
Publicado: (2022)

Extracorporeal membrane oxygenation
por: Butt, Warwick, et al.
Publicado: (2013)

Extracorporeal Membrane Oxygenation
por: Papa, Joey C., et al.
Publicado: (2009)

Anti-Factor-Xa and Activated Partial Thromboplastin Time Concordance and Outcomes in Adults Undergoing Extracorporeal Membrane Oxygenation: A Secondary Analysis of the Pilot Low-Dose Heparin in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation Randomized Trial
por: Aubron, Cécile, et al.
Publicado: (2023)

The Tick-Derived Anticoagulant Madanin Is Processed by Thrombin and Factor Xa
por: Figueiredo, Ana C., et al.
Publicado: (2013)

Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation
por: Carpenter, Elise, et al.
Publicado: (2019)

Low vs standardized dose anticoagulation regimens for extracorporeal membrane oxygenation: A meta-analysis
por: Lv, Xiaochai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_trqjn3od7h0si3op1g86t3f0ir